Montelukast Prescribing at WORTHING MEDICAL GROUP
Cromoglycate, leukotriene and phosphodesterase type-4 inhib | Respiratory System
Items (12m)
1,345
Total Quantity
38.2K
NHS Cost
£2.2K
vs National Avg
+96.4%
WORTHING MEDICAL GROUP prescribed 1,345 items of Montelukast over the last 12 months at a cost of £2,170 to the NHS. This is 96.4% above the national average prescribing rate. Montelukast is classified under Cromoglycate, leukotriene and phosphodesterase type-4 inhib in the BNF.
Monthly Prescribing Trend
Jul 2026
107
Jul 2026
112
Jul 2026
129
Jul 2026
100
Jul 2026
113
Jul 2026
125
Jul 2026
106
Jul 2026
125
Jul 2026
109
Jul 2026
103
Jul 2026
111
Jul 2026
105
Prescribing Details
| Total Items | 1,345 |
|---|---|
| Total Quantity | 38,227 |
| Total NHS Cost | £2,170 |
| Presentations | 5 different forms |
| vs National Average | +96.4% |
Montelukast Prescribing Comparison
| This practice | 1,345 items |
|---|---|
| National average per practice | 685 items |
| Difference | +96.4% vs national average |
Explore More
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.